Related Experiment Videos
[Coronary angioplasty in octogenarians]
E Ascer1, W A Pimentel Filho, J R Büchler
1Hospital Israelita Albert Einstein, São Paulo.
Arquivos Brasileiros De Cardiologia
|August 1, 1992
Summary
Percutaneous transluminal coronary angioplasty (PTCA) is a safe and effective treatment for coronary artery disease in patients 80 years and older. This study shows high success rates and good long-term survival for octogenarians undergoing PTCA.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Cardiology
Context:
- Coronary artery disease (CAD) poses significant risks for elderly patients.
- Treatment options for octogenarians with CAD are often limited due to comorbidities and frailty.
- Percutaneous transluminal coronary angioplasty (PTCA) offers a less invasive alternative to traditional surgical interventions.
Purpose:
- To evaluate the indications, procedural success, and clinical outcomes of PTCA in patients aged 80 years and above.
- To assess the safety and efficacy of PTCA as a treatment for coronary artery disease in the octogenarian population.
- To analyze the follow-up data, including restenosis rates, myocardial infarction, and survival, in elderly patients post-PTCA.
Summary:
- A total of 36 patients aged 80 and over underwent PTCA for significant coronary artery obstruction (≥70%).
- The procedure was successful in 94.4% of patients, with no emergency surgeries or early deaths.
- Follow-up in 15 patients revealed an 80% survival rate, with only one cardiac-related late death, demonstrating the viability of PTCA in this age group.
Impact:
- PTCA is a feasible and effective revascularization strategy for octogenarian patients with symptomatic coronary artery disease.
- The findings support the use of PTCA in elderly populations, potentially improving quality of life and reducing mortality.
- This study provides valuable data for clinicians considering interventional treatment for very elderly patients with CAD.